Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b81a5eda0046acaa7b584105a93cd52 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3521 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1131 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate |
2012-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7684dc219b8184c0577015275cb1854e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69b136c477889693c8a3b8190325448f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_350efe1d99eb71a7550a7f99b51b2d37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bec09c6e9e2c7a7fcd04238f9f6ee466 |
publicationDate |
2020-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20200122397-A |
titleOfInvention |
Compositions and Methods for Inhibiting Gene Expression of Hepatitis B Virus |
abstract |
The present invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a hepatitis B virus gene. In addition, the present invention is a pharmaceutical composition comprising a pharmaceutically acceptable carrier together with a dsRNA or nucleic acid molecule or a vector encoding the same; A method of treating diseases caused by hepatitis B virus infection using the pharmaceutical composition; And a method of inhibiting the expression of a hepatitis B virus gene in a cell. |
priorityDate |
2011-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |